Article citationsMore>>

Al-Ghaith, T., Almoteiry, K., Alamri, A., Alluhidan, M., Alharf, A., Al-Hammad, B., Aljaffali, I., Seiter, A., Pisani, E., Herbst, C. H., El-Saharty, S., & Alazemi, N. (2020). Strengthening the Pharmaceutical System in the Kingdom of Saudi Arabia: Towards a Medicine Policy to Support Vision 2030 (Health, Nutrition and Population Discussion Paper). World Bank.
https://doi.org/10.1596/35846

has been cited by the following article:

• TITLE: Local Vaccine Manufacturing in Saudi Arabia: Examining the Role of National Legal Frameworks and Strategic Policies

  AUTHORS: Tareq S. Alshammari

  KEYWORDS: Legal framework, Localization, Public Health Law, Saudi Arabia, Vaccine Manufacturing, Vision 2030

  JOURNAL NAME: Beijing Law Review, Vol.16 No.4, October 29, 2025

  ABSTRACT: This research aims to identify and evaluate the key legal issues in local vaccine production in Saudi Arabia, as outlined in the provisions of Vision 2030. It examines how evolving domestic legal frameworks—including sectoral laws, regulatory reforms, and national policies—enable or limit successful vaccine localization. Through qualitative documentary analysis, the study finds that Saudi Arabia’s legal reforms have significantly improved the regulatory environment, enabling the rapid development of local partnerships and manufacturing capacity. However, Vision 2030, while driving broad policy change, is ultimately a high-level catalyst. The effective realization of local vaccine manufacturing depends on granular legal adaptation, stronger enforcement, sustained interagency coordination, and continual legal learning. These legal advances have important implications for public health law, boosting resilience, access, and system reliability. The paper concludes with policy recommendations for maximizing the opportunities and addressing the persistent barriers encountered in Saudi vaccine law as the country continues its journey toward health sovereignty.